Viewing nowCombinationRosucande Tablet 5/16mg
Rosuvastatin Calcium 5.2mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Daekyung I-Tech Co., Ltd.

MFDS item code 202107119 · Approved 2021.10.25 · Insurance code 073000760
Improvement of dyslipidemia; treatment of hypertension and heart failure; inhibition of atherosclerosis progression and cardiovascular risk
This medication is utilized for patients requiring simultaneous administration of two drugs: Candesartan Cilexetil and Rosuvastatin. Candesartan Cilexetil is primarily used in the treatment of essential hypertension and heart failure patients with diminished left ventricular function, especially when additional therapy is necessary for ACE inhibitors or if there is poor tolerance. Rosuvastatin is used as an adjunct when diet and exercise do not adequately control hypercholesterolemia and mixed dyslipidemia. It is also applied in patients with familial hypercholesterolemia or to delay the progression of atherosclerosis. It particularly helps reduce the risks of stroke, myocardial infarction, and vascular reintervention in patients at high risk for cardiovascular diseases. Therefore, this medication is used to simultaneously manage hypertension and cholesterol issues to improve cardiovascular health.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, candesartan cilexetil and rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of 2 weeks or more and increased to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 mg once daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20 mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
○ Candesartan cilexetil, essential hypertension: Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. ○ Candesartan cilexetil, heart failure: Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.
This medication may cause serious harm to the fetus if taken during pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Do not take this medication if you are allergic to it or if you have liver disease, severe liver impairment, or are pregnant or breastfeeding. Special caution is needed in elderly patients, patients with hyperkalemia, liver disease, kidney disease, and myopathy, and they should follow their doctor's instructions. If symptoms such as muscle pain or weakness occur, consult a doctor immediately, and if these symptoms are severe, discontinuation of the medication may be necessary. This medication can affect liver and kidney function, so regular blood tests and liver function tests are required. When combined with other antihypertensives, diuretics, or potassium supplements, blood potassium levels and kidney function should be monitored periodically. Alcohol consumption or vigorous exercise may increase the risk of side effects from this medication, so caution is advised. This medication may interact with certain drugs, so be sure to inform your doctor or pharmacist of any other medications you are taking. Be cautious driving or operating machinery, as dizziness or fatigue may occur. Keep out of reach of children and store in the original container to prevent misuse.
Headache, nasopharyngitis, localized infection, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, indigestion, increased blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, nausea, orthostatic dizziness, chest discomfort, musculoskeletal pain, neck pain, increased blood pressure, orthostatic hypotension, cerebral infarction, spondyloarthritis myelopathy, musculoskeletal discomfort, pneumonia, femur fracture, contusion, unstable angina, idiopathic pulmonary fibrosis, wet cough, worsening hypertension, unstable blood pressure, vertigo, positional vertigo, adrenal insufficiency, paralysis, tension hyperreactivity, syncope, facial flushing, weight gain, facial edema, thirst, sleep disorders, decreased libido, forgetfulness, anorexia, increased appetite, tinnitus, taste distortion, erectile dysfunction, constipation, abdominal pain, pancreatitis, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, vascular edema, blood and lymphatic system abnormalities, leukopenia, neutropenia, agranulocytosis, hyperkalemia, hyponatremia, hypoglycemia, weakness, hunger, cold sweat, hand tremor, decreased concentration, convulsions, altered consciousness, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscular dystrophy, oculobulbar myasthenia, acute kidney failure, oliguria, increased serum creatinine, increased ALT, increased CK, joint pain, numbness, sensory disturbances, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to avoid exposure to air and moisture. It is important to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. This will safely preserve the medication's effectiveness.
Pink colored round film-coated tablet
30 tablets/box [10 tablets/PTP x3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Daekyung I-Tech Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.